ANI Pharmaceuticals forecasts FY revenue of USD 1,085–1,125 million
The company’s FY revenue outlook compares with an IBES estimate of USD 1,102 million.
Related stories
Resolute Holdings Management Reports 3Q Sales of $509.6M
M impact | EARNINGS | Nov 05, 2026, 12:07 PM UTC
GPGI Sees 2026 Adjusted EBITDA of $520M-$550M
M impact | EARNINGS | Nov 05, 2026, 12:06 PM UTC
GPGI Sees 2026 Adjusted Net Sales of $2.03B-$2.06B
M impact | EARNINGS | Nov 05, 2026, 12:06 PM UTC
ConocoPhillips Sees Fourth-Quarter Production at 2.32M–2.36M BOE/Day
M impact | EARNINGS | Nov 05, 2026, 12:06 PM UTC
Bobs Discount Furniture Sees FY2026 Adjusted EPS of $0.90-$0.96
Bobs Discount Furniture affirmed FY2026 sales guidance of $2.600 billion-$2.625 billion, versus the $2.612 billion estimate. It sees adjusted EPS of $0.90-$0.96.
M impact | EARNINGS | Nov 05, 2026, 12:05 PM UTC
Bobs Discount Furniture Affirms FY2026 Sales Guidance
The company affirmed FY2026 sales guidance of $2.600 billion to $2.625 billion, versus a $2.612 billion estimate.
L impact | EARNINGS | Nov 05, 2026, 12:05 PM UTC